Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sutro Biopharma (STRO) Prepaid Assets (2017 - 2025)

Sutro Biopharma's Prepaid Assets history spans 9 years, with the latest figure at $10.6 million for Q3 2025.

  • For Q3 2025, Prepaid Assets fell 2.51% year-over-year to $10.6 million; the TTM value through Sep 2025 reached $10.6 million, down 2.51%, while the annual FY2024 figure was $17.8 million, 80.77% up from the prior year.
  • Prepaid Assets for Q3 2025 was $10.6 million at Sutro Biopharma, down from $18.5 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $24.9 million in Q1 2025 and bottomed at $7.5 million in Q1 2021.
  • The 5-year median for Prepaid Assets is $10.3 million (2023), against an average of $11.8 million.
  • The largest annual shift saw Prepaid Assets surged 232.69% in 2021 before it crashed 43.13% in 2024.
  • A 5-year view of Prepaid Assets shows it stood at $8.1 million in 2021, then surged by 43.63% to $11.7 million in 2022, then decreased by 15.61% to $9.8 million in 2023, then skyrocketed by 80.77% to $17.8 million in 2024, then plummeted by 40.46% to $10.6 million in 2025.
  • Per Business Quant, the three most recent readings for STRO's Prepaid Assets are $10.6 million (Q3 2025), $18.5 million (Q2 2025), and $24.9 million (Q1 2025).